ISSN: 2167-7689
Pharmaceutical Regulatory Affairs: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business
 

Electrochemical Detection versus Ultraviolet Detection

Hideharu Shintani*
Chuo University, School of Science, 1-13-27, Kasuga, Bunkyo, Tokyo 112-8551, Japan
Corresponding Author : Hideharu Shintani
Faculty of Science and Engineering
Chuo University, 1-13-27, Kasuga
Bunkyo, 112-8551, Tokyo, Japan
Tel: +81425922336
Fax: +81425922336
E-mail: shintani@mail.hinocatv.ne.jp
Received April 08, 2014; Accepted April 09, 2014; Published April 28, 2014
Citation: Shintani H (2014) Electrochemical Detection versus Ultraviolet Detection. Pharmaceut Reg Affairs 3:e130. doi: 10.4172/2167-7689.1000e130
Copyright: © 2014 Shintani H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Pharmaceutical Regulatory Affairs: Open Access

Electrochemical detection (ED) is used for the sensitive detection and measurement of electro-active analytes in many areas of analytical chemistry and biochemistry. These applications range from electrode sensor devices via flow injection analyses to direct measurements of neurochemicals in brain tissue using in vivo cyclic voltammetry. In separation science, ED is used to detect and measure responsive analytes in flowing streams following analysis by high-performance liquid chromatography (HPLC) or capillary electrophoresis (CE). The use of ED with HPLC is by far and away the most important application of ED in flowing systems. The use of HPLC-ED grew by 5 times between the 1980s and the 1990s. However, its popularity should be compared to HPLC with fluorescence detection and HPLC with MS detection. Most published HPLC methods use UV/VIS detection without fail.
Unlike UV or fluorescence detectors, ED does not exploit a physical property of an analyte, but an induced chemical change that results from an electrochemical reaction. ED must, therefore, be considered to be a type of post-column chemical reaction detector. ED differs, however, from other post-column reactors used in HPLC in that no reagents or reaction devices are normally required to effect the chemical change in the analyte. In addition, the reaction kinetics are usually fast leading to minimal extra-column effects. With UV detectors, selectivity is adjusted by varying the detection wavelength, lower wavelengths often giving enhanced sensitivity and a response from a wider range of analytes. A modest degree of selectivity is achieved by using UV detection in the aromatic region (240-270 nm) and traditionally 254 nm has proved popular. However, at lower wavelengths (200-210 nm), the absorption of the eluent, of other eluent constituents or of oxygen become limiting. Relatively few compounds show useful absorption at wavelengths higher than 340 nm (the lower limit of the deuterium lamp emission). Generally, responses are usually independent of eluent conditions. In ED detection both sensitivity and selectivity are adjusted by varying the potential maintained between the working and reference electrodes, higher potentials, up to a local maximum, giving increased sensitivity. However, higher potentials usually induce a response from more compounds and therefore compromise selectivity. In oxidative mode, oxidation of eluent constituents becomes limiting at higher applied potentials, whilst in reductive mode, interference from dissolved oxygen can prove difficult to exclude. The response at the electrode is also very dependent on the eluent composition, especially its pH. Thus, as in all analytical methods, it is the signal-to-noise (S/N) ratio that is important and the detection conditions eventually adopted for a separation are a compromise between the electrochemical response of the analyte, the optimum eluent for both detection and elution, and interference from the sample matrix or from noise or drift from electronic or other sources.
In HPLC-ED the column elute flows over the surface of an ‘inert’ electrode maintained at an appropriate positive or negative potential relative to a reference electrode. At the electrode surface analytes possessing electro active functional groups undergo oxidation or reduction. The electrons released travel via the electrode and the change in current can be measured and related to the concentration of the analyte. Modem electronics allow the applied (working) potential to be held within very tight limits while at the same time measuring and amplifying the very small currents created. Hence ED can be very sensitive. Both ED and fluorescence detectors can be at least 100 times more sensitive towards responsive compounds than a standard UV detector and are much more selective. Unfortunately, with time electrochemical reaction products tend to accumulate at the electrode surface leading to loss of activity and hence loss of detector response - this is the major reason ED remains a relatively specialized field compared with UV detection, which is much popular even though less sensitive and selective due to an easy handling.
The readers can choose which detectors may be the most appropriate detector for your purpose from the characteristics of the compound(s) of interest to determine in your study.
Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc
Disc Advances in Bioavailability
Disc Advances in pharmaceutical analytical methods
Disc Adverse Effects
Disc Air analysis
Disc Anvisa Bioequivalence
Disc Anvisa regulatory guidelines
Disc BA/BE Studies
Disc Bioequivalence Anticancers
Disc Bioequivalence Antidiabetics
Disc Bioequivalence Antidiuretics
Disc Bioequivalence Antipsychotics
Disc Bioequivalence Cardiovascular Products
Disc Bioequivalence Study Design
Disc Bioequivalence Study Protocols
Disc Biopharmaceutics
Disc Biosimilars
Disc British regulatory guidelines
Disc Causality Assesment
Disc Chemical analysis
Disc Clinical Cancer Trials
Disc Clinical Drug Trial
Disc Clinical Pharmacovigilance
Disc Clinical Trials Pharmacovigilance
Disc Competitive analysis of drugs
Disc Drug Monitoring
Disc Drug Safety Survillance
Disc Drug analysis
Disc Drug devices
Disc Europe Pharmacovigilance
Disc European Bioequivalence
Disc Europian regulatory guidelines
Disc Experimental Drug Trial
Disc FDA Bioequivalence
Disc Good Pharmacovigilance Practice
Disc In vitro Bioequivalence
Disc Japan Pharmacovigilance
Disc Japan regulatory guidelines
Disc Medical Literature
Disc Medical devices regulations
Disc Medication Error
Disc Paid Clinical Trials
Disc Periodic Safety Update Reports
Disc Pharma Risk Management
Disc Pharmaceutical analysis
Disc Pharmaceutical analytical market
Disc Pharmaceutical care
Disc Pharmaceutical companies and regulatory guidelines
Disc Pharmaceutical ethics
Disc Pharmaceutical formulation
Disc Pharmaceutical technology
Disc Pharmaceutics
Disc Pharmacovigilance Regulatory Updates
Disc Pharmacovigilance and Risk Management
Disc Pharmacovigilance for Alternative Medicine
Disc Product analysis and marketing
Disc Quality assurance in pharmaceutical analysis
Disc Quality assurance in regulatory affairs
Disc Regulatory Requirements in Bioequivalence
Disc Regulatory affairs
Disc Regulatory affairs for clinical trails
Disc Regulatory compliance
Disc Regulatory consulting and market analysis
Disc Regulatory requirements of pharmaceutical products
Disc Regulatory services and market analysis
Disc Spectrometry
Disc UK Pharmacovigilance
Disc US FDA guidelines
Disc US Pharmacovigilance
Disc Validation
Disc Veterinary Pharmacovigilance
 
Recommended Journals
Disc Pharmacovigilance Journal
Disc Pharmaceutical Analysis Journal
Disc Bioequivalence Journal
  View More»
 
Recommended Conferences
Disc 6th Pharmaceutical Regulatory Affairs
September 15-16, 2016, San Antonio, USA
Disc 7th Analytical Techniques Conference
September 29-Oct 1, 2016, Miami, USA
Disc Pharmaceutical Methods Development Conference
October 20-22, 2016, Dubai, UAE
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11196
  [From(publication date):
October-2014 - Jun 25, 2016]
  Breakdown by view type
  HTML page views : 7465
  PDF downloads :3731
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version